​

Funding Round

Series A - Ochre Bio

Series A - Ochre Bio

Investment Firm

Overview

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Announced Date

Oct 10, 2022

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Khosla Ventures

Khosla Ventures

Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

10

Investor Name
Participant InvestorEIT Health
Participant InvestorAlice Zhang
Participant InvestorBACKED VC
Participant InvestorMartin Chavez
Participant InvestorKhosla Ventures

Round Details and Background

Ochre Bio raised $30000000 on 2022-10-10 in Series A

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 16, 2020
Seed Round - Ochre Bio
2-150.0K
Jun 16, 2021
Seed Round - Ochre Bio
6-9.6M
Dec 10, 2021
Series A - Ochre Bio
6-undefined
Oct 10, 2022
Series A - Ochre Bio
11-30.0M

Recent Activity

There is no recent news or activity for this profile.